Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Emory University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute